Dassault Systèmes in talks to buy drug trial software group for about $2bn

retained text

No document body was retained for this record — only its metadata was stored.

document fetched 2026-07-17 08:05 · canonical https://ft.com/content/72c335dd-11c9-4ba0-bd11-41414df06d97?syn-25a6b1a6=1